| 7/6/2021 |
FDA Approves Expanded Indication for Merck's KEYTRUDA® (pembrolizumab) in Locally Advanced Cutaneous Squamous Cell Carcinoma (cSCC) | Business Wire |
Business Wire |
KENILWORTH, N.J.--( BUSINESS WIRE )--Merck (NYSE: MRK), known as MSD outside the United States and Canada, today announced that the U.S. Food and Drug Administration (FDA) has approved an expanded label for KEYTRUDA, Merck’s anti-PD-1 therapy, as monotherapy for the treatment of patients with locally advanced cutaneous squamous cell carcinoma (cSCC) that is not curable by surgery or radiation. This approval is based on data from the ... |
| 7/6/2021 |
FDA Approves Expanded Indication for Merck's KEYTRUDA® (pembrolizumab) in Locally Advanced Cutaneous Squamous Cell Carcinoma (cSCC) |
Yahoo News |
... July 06, 2021 --( BUSINESS WIRE )--Merck (NYSE: MRK), known as MSD outside the United States and Canada, today announced that the U.S. Food and Drug Administration (FDA) has approved an expanded label for KEYTRUDA, Merck’s anti-PD-1 therapy, as monotherapy for the treatment of patients with locally advanced cutaneous squamous cell carcinoma (cSCC) that is not curable by surgery or radiation. This approval is based on data from ... |
| 7/6/2021 |
Global Soybean Trypsin Inhibitor Market Key Insights Of The Business Scenario By 2026 |
PRSync |
Global Soybean Trypsin Inhibitor Market Key Insights Of The Business Scenario By 2026 [IMR Market Reports] - Tuesday, July 6, 2021. Research reports on the 'Global Soybean Trypsin Inhibitor Market' provide a complete study of broad market share, market segmentation and global market participants. This report was created with the help of primary and secondary research methods. This report provides an in-depth study of qualitative and quantitative analysis of supply ... |
| 7/6/2021 |
Live Vaccines US Market Research Report 2021-2026 |
isblog.net |
... Children ALSO READ : [http://www.marketwatch.com/story/june-2021-report-on-global-flower-and-fruit-tea-market-outlook-industry-analysis-and-prospect-2021-2026-2021-06-03] The key market players for global Live Vaccines market are listed below: Merck GlaxoSmithKline Pfizer Novartis Astellas Pharma Emergent BioSolutions AstraZeneca Market segment by Region, regional analysis covers North America (United States, Canada and Mexico) Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe) Asia-Pacific ... |
| 7/6/2021 |
Global Special-effect Pigment Market outlook Opportunities and Demand Analysis, Forecast 2020-2026 |
PRSync |
IMR Market Reports - Tuesday, July 6, 2021.Research reports on the 'Global Special-effect Pigment Market' provide a complete study of broad market share, market segmentation and global market participants. This report was created with the help of primary and secondary research methods. This report provides an in-depth study of qualitative and quantitative analysis of supply chain, consumer requirements and consumer demand.Increased competition between the organizational and non ... |
| 7/6/2021 |
Global Special Effect Pigments Market Projected to Grow at a Steady Pace During 2021-2026 |
PRSync |
IMR Market Reports - Tuesday, July 6, 2021.Research reports on the 'Global Special Effect Pigments Market' provide a complete study of broad market share, market segmentation and global market participants. This report was created with the help of primary and secondary research methods. This report provides an in-depth study of qualitative and quantitative analysis of supply chain, consumer requirements and consumer demand.Increased competition between the organizational and non ... |
| 7/6/2021 |
Hipgnosis has spent $1billion on artist catalogues in the past year |
nme.com |
... be worth an estimated $150 million (£110 million). Shakira also sold all 145 of her songs, including ‘Hips Don’t Lie’, ‘She Wolf’ and ‘Whenever, Wherever’, all part of the deal. Merck Mercuriadis, Hipgnosis Songs Fund CEO , told Music Week: “We are delighted to announce a strong set of annual results which reports on a remarkable year for Hipgnosis… This strong return evidences not only our ... |
| 7/6/2021 |
Barrier CMP Slurry Analysis, Historic Data and Forecast 2021-2028 |
alltdesign.com |
... cmp-slurry-market-size-share-value-and-competitive-landscape-2021---2026-2021-06-03] Segment by Type Copper Barrier Slurry Tantalum Barrier Slurry Segment by Application Logic NAND DRAM Others By Company CMC Material DuPont Fujifilm Ferro Merck (Versum Materials) Fujimi Corporation Hitachi Anjimirco Shanghai Also Read: [http://www.marketwatch.com/story/june-2021-report-on-global-worldwide-armoured-glass-market-outlook-industry-analysis-and-prospect-2021-2026-2021-06-03] Production by Region North America Europe China Japan ... |
| 7/6/2021 |
Antimicrobial Susceptibility Testing Market Shared in Detailed Report |
timestechpharma.com |
... Academic InstitutesClinical Research Organizations (CROs)The key players operating in Antimicrobial Susceptibility Testing Market such as Alifax, Becton Dickinson and Company (BD), Biomerieux, Bio-Rad Laboratories, Inc, Creative Diagnostics, Danaher Corporation, HiMedia Laboratories, Merck KGaA, Resistell AG, Thermo Fisher Scientific Inc, and others. now/0/2438 Antimicrobial Susceptibility Testing Market BY PRODUCT CHAPTER 5. Antimicrobial Susceptibility Testing Market BY MATERIAL CHAPTER 6. Antimicrobial Susceptibility Testing Market BY PACKAGING TYPE CHAPTER ... |
| 7/6/2021 |
Impact of Covid-19 on Interferon Beta Drugs Market 2020, Size, Share, Global Industry Challenges, Business Overview and Forecast Research Study 2027 |
timestechpharma.com |
Drug StoresOnline PharmaciesThe key players operating in Interferon Beta Drugs Market such as A S Biotech, Apple Pharmaceuticals, Bayer, Biogen Idec., Hoffmann-La Roche Ltd, Merck KGaA, Mili Healthcare, Novartis AG, Pfizer Inc, and Rewine Pharmaceutical.Along with this, the research report encompasses comprehensive information of market leaders that majorly include a business overview, financial overview, product offerings, strategic developments, and geographical presence. The profiled players are collaboratively ... |
| 7/6/2021 |
Foreign-Trade Zone (FTZ) 185-Culpeper, Virginia, Authorization of Production Activity, Merck & Co., Inc. (Pharmaceutical Products), Elkton, Virginia |
federalregister.gov |
Notice On March 2, 2021, Merck & Co., Inc., submitted a notification of proposed production activity to the FTZ Board for its facility within Subzone 185C, in Elkton Virginia. The notification was processed in accordance with the regulations of the FTZ Board ( 15 CFR part 400 ), including notice in the Federal Register inviting public comment ( 86 FR 13524 , March 9, 2021). On ... |
| 7/6/2021 |
Dementia Drugs Market Analysis and Forecast 2020: By Acumen Research and Consulting |
pharmanewsdesk.com |
Hospital PharmaciesOthersThe key players operating in Dementia Drugs Market such as Janssen Pharmaceuticals, Inc., Biogen Pharmaceuticals, Forest Laboratories, Inc., Eli Lilly and Company, Novartis AG, Sanofi S.A., AstraZeneca, F. Hoffmann-La Roche, Merck and Co., Inc., Valeant Pharmaceutical International, Eisai, Inc., Pfizer Inc., and Teva Pharmaceuticals Industries Ltd.Along with this, the research report encompasses comprehensive information of market leaders that majorly include a business overview, financial overview ... |
| 7/6/2021 |
Global Implantable Drug-Eluting Devices Market Overview 2021: Global Demand Analysis & Opportunities Outlook 2026 Pfizer, Boston Scientific Corporation, Bayer AG |
PRSync |
... the forecast period. This report covers all aspects of the Implantable Drug-Eluting Devices industry, including market sales, technical thinking, and business profiles. Key Players Mentioned: Pfizer, Boston Scientific Corporation, Bayer AG, Medtronic, Surmodics, Merck , BIOTRONIK, Abbott, Johnson & Johnson, Titan Pharmaceuticals Inc., Allergan, MicroPort Medical, Bausch & Lomb, REVA Medical For Right Perspective & Competitive Insights, Request a Sample @: https://www.imrmarketreports.com/request/7603 This report provides a thorough overview of the competitive ... |
| 7/5/2021 |
Global Inactivated Vaccine Market Research Report 2021 Professional Edition |
reportsnreports.com |
... bacteria, or they may consist of fragments that cleave together to form a cleaved vaccine. By Market Verdors: Astellas Pharma (Japan) CSL Limited (Australia) Emergent BioSolutions (U.S.) GlaxoSmithKline (U.K.) Johnson & Johnson (U.S.) MedImmune (U.S.) Merck & Co (U.S.) Pfizer (U.S.) Sanofi Pasteur (France) Serum Institute of India Pvt (India) By Types: Children Adult By Applications: Hospital Medical Center Key Indicators Analysed Market Players & Competitor Analysis: The report covers the key players ... |
| 6/29/2021 |
Human Growth Hormone Market 2020 In-Depth Analysis of Industry Share, Size, Growth Outlook up to 2027 | Novartis AG (Sandoz International GmbH),Eli Lilly and Company,Merck & Co. |
Wordpress.com |
A report was released recently that sheds lots of light on the Human Growth Hormone Industry. The report covers an overview of the industry along with a detailed explanation that provides a lot of insight. The report also analyzes the production as well as management technology in various end-user industries. An in-depth study in some new and prominent industry trends, analysis of the competition and regional analysis that ... |
| 6/29/2021 |
Global Graft Versus Host Disease (GVHD): Market Size from 2018 to 2030 and Overview of Treatment Practices and Emerging Drugs |
PR Newswire |
DUBLIN , June The "Graft Versus Host Disease (GVHD) - Market Insight, Epidemiology and Market Forecast - 2030" report has been added to ResearchAndMarkets.com's offering.This 'Graft-versus-host disease (GvHD) - Market Insights, Epidemiology, and Market Forecast - 2030' report delivers an in-depth understanding of the GvHD, historical and forecasted epidemiology as well as the GvHD market trends in the United States , EU5 ( Germany , France , Italy , Spain , and United Kingdom ), and Japan . The ... |
| 6/29/2021 |
Multiple sclerosis: structural and functional integrity of the visual system following alemtuzumab therapy |
BMJ |
... at the University of Sydney, and is an employee at Sydney Neuroimaging Analysis Centre (SNAC). JB has received honoraria for talks and advisory boards and support for scientific meetings from Sanofi-Genzyme, Novartis, Teva, Merck and Biogen. KK and LL are employees at SNAC. YB is a consulting neuroradiologist for SNAC. HB has received honoraria for presentations and advisory boards; and has received educational travel support from Biogen, Genzyme, Merck ... |
| 6/28/2021 |
Ault Global Holdings Announces Agreement to Acquire up to 40% of Adtech Pharma, Inc. | Financial Buzz |
financialbuzz.com |
... Adtech’s Vice President of R&D and was formerly with AbbVie, Kos Pharmaceuticals and Rhodes Pharmaceuticals; Ping Chang, PhD, is Adtech’s Vice President of Operations and was formerly with Pfizer, Schering Plough, Merck , Rhodes Technologies, and Rhodes Pharmaceuticals; and Iok-Hou Pang, PhD, is Adtech’s Vice President of Product Development, and was formerly with Alcon, Novartis, and is the founding chair of the University of North Texas ... |
| 6/28/2021 |
Lumos Pharma Announces OraGrowtH212 Trial of LUM-201 in PGHD Is Open for Enrollment |
Globe Newswire |
... moderately growth hormone deficient subset of pediatric patients with PGHD. Similar PK/PD data showing a dose-related response and increased pulsatile release of GH was previously documented in Phase 2 studies conducted by Merck in adults and in a small subset of PGHD patients. The OraGrowtH212 Trial is being conducted at the Research Institute of Mother and Child Care, an institute of the University of Chile, at the San ... |
| 6/28/2021 |
CDC, FDA Prepare Mass Distribution of a Merck/Sanofi Six-in-One Vaccine for Kids, Turning Blind Eye to Safety Signals |
Wordpress.com |
... perpetual pin cushions, drug makers and doctors have a ready answer — combination vaccines that “simplify” the schedule by decreasing the number of injections administered.This month marks the U.S. launch of the Merck/Sanofi joint-venture vaccine, Vaxelis, a six-in-one (hexavalent) combination vaccine that contains diphtheria, tetanus and acellular pertussis (DTaP) components as well as components said to protect against polio, Haemophilus influenzae type b (Hib ... |